Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 11
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
40 to 90
Pharmaceutical / Industry
AVO108943
NCT00470834
2.
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Approved-not yet active
35 to 90
Other, Pharmaceutical / Industry
047838
NCT00805701
3.
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
45 to 80
Other
CURC/CUOG-AVIAS-0601
NCT00553878
4.
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
Other
CCF IRB 8019
GSK106046 (formerly 103988), NCT00244309
Last Modified:
6/9/2008
 
First Published:
11/3/2006
5.
Phase III Randomized Study of Dutasteride Followed By Contrast-Enhanced, Ultrasound-Guided Targeted Biopsy for the Detection of Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic
Active
18 to 80
NCI
TJUH-06F-145
NCT00398281
6.
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Active
40 to 80
Other
BE-2-27
NCT00780754
7.
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
05-8538-V 01
FHCRC-05026, NCT00298155
Last Modified:
1/13/2009
 
First Published:
8/10/2007
8.
Phase II Randomized Study of Dutasteride and Intermittent Androgen-Ablation Therapy in Patients Who Have Undergone Prior Radiotherapy and/or Surgery for Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
45 to 80
NCI
FHCRC-6408
6408, UWCC-UW 6408, UWCC- 06-4211-H/B, NCT00516815
9.
ARTS - AVODART After Radical Therapy For Prostate Cancer Study
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 85
Pharmaceutical / Industry
ARI109924
NCT00558363
10.
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
Other
EH07-109
NCT00668642
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute